Baird Medical Investment Holdings Limited Stock-Based Compensation
Baird Medical Investment Holdings Limited (BDMD) reported Stock-Based Compensation of $17.47 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-07-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-27
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|
| 2025-12-31 | $17.47M 20-F/A · filed 2026-07-27 | |
| 2025-06-30 | $6.33M 6-K · filed 2025-12-05 |